Paolo Aluffi Valletti1, Matteo Brucoli2, Paolo Boffano3, Arnaldo Benech2, Andrea Toso1, Valeria Dell'Era1, Massimiliano Garzaro1. 1. ENT Division, University Hospital "Maggiore della Carità", University of Eastern Piedmont, Novara, Italy. 2. Division of Maxillofacial Surgery, University Hospital "Maggiore della Carità", University of Eastern Piedmont, Novara, Italy. 3. Division of Maxillofacial Surgery, University Hospital "Maggiore della Carità", University of Eastern Piedmont, Novara, Italy. paolo.boffano@gmail.com.
Abstract
INTRODUCTION: Lymphangiomas are relatively uncommon head and neck region lymphatic malformations. Although surgery can be still considered the mainstay of treatment, sclerotherapy by OK-432 is becoming a widespread treatment option. The aim of this article is to present and discuss the management and outcomes of a series of cases of lymphangiomas. METHODS: All patients with lymphangiomas who were treated from 2010 to 2018 were reviewed. The following data were recorded: age, gender, subtype, staging, type of treatment, outcome, and recurrence. RESULTS: Fifteen patients (9 females, 6 males) were included with 2 microcystic and 13 macrocystic lymphangiomas. Six patients underwent surgery with excision (5 with a complete success, one with a fair success), whereas the remaining 9 subjects underwent sclerotherapy by OK-432 (6 with a complete success, 3 with a fair success). No postoperative complications were observed. CONCLUSIONS: All modes of treatment are important in properly selected patients affected by lymphangiomas. OK-432 therapy is a safe and effective option in the treatment of head and neck lymphangiomas.
INTRODUCTION:Lymphangiomas are relatively uncommon head and neck region lymphatic malformations. Although surgery can be still considered the mainstay of treatment, sclerotherapy by OK-432 is becoming a widespread treatment option. The aim of this article is to present and discuss the management and outcomes of a series of cases of lymphangiomas. METHODS: All patients with lymphangiomas who were treated from 2010 to 2018 were reviewed. The following data were recorded: age, gender, subtype, staging, type of treatment, outcome, and recurrence. RESULTS: Fifteen patients (9 females, 6 males) were included with 2 microcystic and 13 macrocystic lymphangiomas. Six patients underwent surgery with excision (5 with a complete success, one with a fair success), whereas the remaining 9 subjects underwent sclerotherapy by OK-432 (6 with a complete success, 3 with a fair success). No postoperative complications were observed. CONCLUSIONS: All modes of treatment are important in properly selected patients affected by lymphangiomas. OK-432 therapy is a safe and effective option in the treatment of head and neck lymphangiomas.
Entities:
Keywords:
Head and neck; Lymphangioma; Maxillofacial malformation; OK-432; Plastic surgery; Surgery
Authors: J Lerat; C Mounayer; A Scomparin; S Orsel; J-P Bessede; K Aubry Journal: Eur Ann Otorhinolaryngol Head Neck Dis Date: 2016-08-03 Impact factor: 2.080
Authors: M Hamoir; I Plouin-Gaudon; P Rombaux; G Francois; A S Cornu; G Desuter; P Clapuyt; C Debauche; G Verellen; C Beguin Journal: Head Neck Date: 2001-04 Impact factor: 3.147
Authors: R De Leacy; D V Bageac; S Manna; B S Gershon; D Kirke; T Shigematsu; C Sinclair; D Chada; P Som; A Doshi; K Nael; A Berenstein Journal: AJNR Am J Neuroradiol Date: 2021-08-26 Impact factor: 4.966
Authors: Jaylou M Velez Torres; Ernesto Martinez Duarte; Julio A Diaz-Perez; Jason Leibowitz; Donald T Weed; Giovanna Thomas; Zoukaa Sargi; Francisco J Civantos; David J Arnold; Carmen Gomez-Fernandez; Elizabeth A Montgomery; Andrew E Rosenberg Journal: Head Neck Pathol Date: 2021-07-12